Publication | Open Access
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
193
Citations
52
References
2018
Year
Hematological MalignancyClonal HeterogeneityMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaImmunologyHematologyPathologyMyeloid NeoplasiaIdh2 Inhibitor EnasidenibMalignant Blood DisorderOncologyRadiation OncologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1